EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Year Ended 31St March, 2024
EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve the financial results for the year ended 31st March, 2024 EP Biocomposites Ltd - 543595 - Regu. 7 (3) Compliance Certificate For The Financial Year 2023-24
Regu. 7 (3) Compliance Certificate for the Financial Year 2023-24 EP Biocomposites Ltd - 543595 - Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the above, certificate received from Bigshare Services Private Limited, RTA of the Company, is hereby enclosed. EP Biocomposites Ltd - 543595 - Closure of Trading Window
This is to inform you that the Company has closed the trading window for the earnings release of the financial year ending March 31, 2024 in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, from April 1, 2024. EP Biocomposites Ltd - 543595 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Award Of Order
The Company has received an order of INR 4.9 Crores for the construction of 4 intermediate pumping stations (manhole to manhole) and raising main in Taleigao constituency, Goa. EP Biocomposites Ltd - 543595 - Award Of An Order For Design, Supply, Installation, Testing And Commissioning Of Sewage Treatment Plant (STP) Of 100 KLD Capacity (MBR Based)
Award of an order for design, supply, installation, testing and commissioning of sewage treatment plant (STP) of 100 KLD capacity (MBR based) from Oil and Natural Gas Corporation Limited EP Biocomposites Ltd - 543595 - Unaudited Financial Results For The Half Year Ended September 30, 2023 With Statement Of Assets And Liabilities
Unaudited financial results for the half year ended September 30, 2023 duly approved by the Board of Directors of the Company in their meeting held today along with the Limited Review Report by the Auditors of the Company EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Intimation Of The Board Meeting
The unaudited Financial Results for the Half Year ended September 30, 2023 were duly approved by the Board of Directors of the Company in their meeting held today i.e. November 14, 2023 together with Statement of Assets and Liabilities EP Biocomposites Ltd - 543595 - Board Meeting Intimation for The Consideration And Approval Of Draft Financial Results For The Half Year Ended September 30, 2023
EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results for half-year ended September 30, 2023. EP Biocomposites Ltd - 543595 - Intimation Under Regulation 30 (LODR)
Resignation of Company Secretary and Compliance Officer